The Pandemic Effect: COVID-19’s Impact on the Drug Development Regulatory Landscape

In this Pharmaceutical Outsourcing article, Aman Khera describes how the coronavirus health crisis has brought attention to global regulatory challenges impacting drug development.

Authors:

Aman Khera, MBA, FTOPRA, FRAPS

VP, Regulatory Science, Strategy and Innovation